Disease management--constructing optimal NRTI-based combinations: past, present, and future.
- 19 January 2006
- journal article
- review article
- Vol. 8 (1) , 16
Abstract
No abstract availableThis publication has 58 references indexed in Scilit:
- Efficacy and Safety of Tenofovir DF vs Stavudine in Combination Therapy in Antiretroviral-Naive PatientsA 3-Year Randomized TrialJAMA, 2004
- HIV Drug ResistanceNew England Journal of Medicine, 2004
- Initiating HIV TherapyPostgraduate Medicine, 2004
- Clinical efficacy of antiretroviral combination therapy based on protease inhibitors or non-nucleoside analogue reverse transcriptase inhibitors: indirect comparison of controlled trialsBMJ, 2004
- Changing patterns of mortality across Europe in patients infected with HIV-1The Lancet, 1998
- Treatment with Lamivudine, Zidovudine, or Both in HIV-Positive Patients with 200 to 500 CD4+ Cells per Cubic MillimeterNew England Journal of Medicine, 1995
- A Controlled Trial of Early versus Late Treatment with Zidovudine in Symptomatic Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1992
- Zidovudine in Asymptomatic Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1990
- Failure of Zidovudine to Maintain Remission in Patients with AIDSNew England Journal of Medicine, 1989
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987